Eight patients with pancreatic neoplasia were confirmed by surgery or fine-needle aspiration (10% yield of screening); of these, six patients had benign intraductal papillary mucinous neoplasms (IPMNs), one had an IPMN that progressed to invasive ductal adenocarcinoma, and one had a PanIN-1.
The Food and Drug Administration has approved Velcade to treat a type of cancer called multiple myeloma. Velcade should only be used in people who have already been treated with two other types of chemotherapy (drugs used to kill cancer cells), and whose cancer has still progressed on the most recent therapy.Velcade is a new type of cancer drug called a proteasome inhibitor.Proteasomes are enzymes found in cells, and play a role in regulating cell function and growth. Velcade blocks the activity of proteasomes. This blockade can lead to death of cancer cells.elcade is a new type of cancer drug called a proteasome inhibitor. Proteasomes are enzymes found in cells, and play a role in regulating cell function and growth. Velcade blocks the activity of proteasomes. This blockade can lead to death of cancer cells.
The active ingredient in Velcade is bortezomib. Velcade is used to treat a type of cancer called multiple myeloma. It should only be used in people who have already been treated with two other types of chemotherapy (drugs used to kill cancer cells), and whose cancer has still progressed on the most recent therapy.o, proteasomes are found in all cells, and are necessary for cells to survive and grow. Velcade may kill some good cells along with the cancer cells, which can lead to side effects. Multiple myeloma is a type of cancer. In multiple myeloma, cancerous plasma cells are found in the bone marrow.